• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对补体 C5a 受体 1 治疗脓毒症免疫抑制。

Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis.

机构信息

Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany; Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.

Applied Systems Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Jena, Germany.

出版信息

Mol Ther. 2021 Jan 6;29(1):338-346. doi: 10.1016/j.ymthe.2020.09.008. Epub 2020 Sep 5.

DOI:10.1016/j.ymthe.2020.09.008
PMID:32966769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7791006/
Abstract

Complement factor C5a was originally identified as a powerful promoter of inflammation through activation of the C5a receptor 1 (C5ar1). Recent evidence suggests involvement of C5a not only in pro- but also in anti-inflammatory signaling. The present study aims to unveil the role of C5ar1 as potential therapeutic target in a murine sepsis model. Our study discloses a significantly increased survival in models of mild to moderate but not severe sepsis of C5ar1-deficient mice. The decreased mortality of C5ar1-deficient mice is accompanied by improved pathogen clearance and largely preserved liver function. C5ar1-deficient mice exhibited a significantly increased production of the pro-inflammatory mediator interferon-γ (IFN-γ) and a decreased production of the anti-inflammatory cytokine interleukin-10 (IL-10). Together, these data uncover C5a signaling as a mediator of immunosuppressive processes during sepsis and describe the C5ar1 and related changes of the IFN-γ to IL-10 ratio as markers for the immunological (dys)function accompanying sepsis.

摘要

补体因子 C5a 最初被鉴定为通过激活 C5a 受体 1(C5ar1)来强力促进炎症反应。最近的证据表明,C5a 不仅参与促炎信号,还参与抗炎信号。本研究旨在揭示 C5ar1 在小鼠脓毒症模型中作为潜在治疗靶点的作用。我们的研究揭示了 C5ar1 缺失小鼠在轻度至中度而非重度脓毒症模型中的存活率显著增加。C5ar1 缺失小鼠的死亡率降低伴随着病原体清除率的提高和肝功能的大量保留。C5ar1 缺失小鼠表现出促炎介质干扰素-γ(IFN-γ)的产生显著增加,抗炎细胞因子白细胞介素-10(IL-10)的产生减少。总之,这些数据揭示了 C5a 信号在脓毒症期间作为免疫抑制过程的介质,并描述了 C5ar1 和相关的 IFN-γ 与 IL-10 比值的变化作为伴随脓毒症的免疫(功能障碍)的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/8c9863e58b96/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/027b146d8fb0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/496ca19f67b9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/65607ebcbf3b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/b3c24f3254bc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/8c9863e58b96/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/027b146d8fb0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/496ca19f67b9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/65607ebcbf3b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/b3c24f3254bc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa6/7791006/8c9863e58b96/gr4.jpg

相似文献

1
Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis.针对补体 C5a 受体 1 治疗脓毒症免疫抑制。
Mol Ther. 2021 Jan 6;29(1):338-346. doi: 10.1016/j.ymthe.2020.09.008. Epub 2020 Sep 5.
2
Complement C5a Receptor 1 Exacerbates the Pathophysiology of Sepsis and Is a Potential Target for Disease Treatment.补体 C5a 受体 1 加重脓毒症的病理生理学改变,是疾病治疗的潜在靶点。
mBio. 2018 Jan 23;9(1):e01755-17. doi: 10.1128/mBio.01755-17.
3
C5aR1 Activation Drives Early IFN-γ Production to Control Experimental Infection.C5aR1 激活驱动早期 IFN-γ 产生以控制实验性感染。
Front Immunol. 2020 Jul 8;11:1397. doi: 10.3389/fimmu.2020.01397. eCollection 2020.
4
Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.补体 C5a 诱导严重创伤患者促炎微囊泡释放。
Front Immunol. 2020 Sep 2;11:1789. doi: 10.3389/fimmu.2020.01789. eCollection 2020.
5
C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.C5a/C5aR1 通过促进 γδ-T 细胞产生 IL-17A 介导 IMQ 诱导的银屑病样皮肤炎症。
FASEB J. 2020 Aug;34(8):10590-10604. doi: 10.1096/fj.202000384R. Epub 2020 Jun 18.
6
The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis.补体因子5a受体1在慢性肾盂肾炎小鼠模型的慢性炎症和肾纤维化中起致病作用。
Kidney Int. 2016 Sep;90(3):540-54. doi: 10.1016/j.kint.2016.04.023. Epub 2016 Jun 28.
7
C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.C5a 受体 1 抑制减轻流感病毒诱导的急性肺损伤。
Int Immunopharmacol. 2018 Jun;59:12-20. doi: 10.1016/j.intimp.2018.03.029. Epub 2018 Apr 2.
8
Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression.C5a-C5aR1 信号转导的调节改变了 AD 进展的动力学。
J Neuroinflammation. 2022 Jul 11;19(1):178. doi: 10.1186/s12974-022-02539-2.
9
Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.补体 C3a 受体、C5a 受体 1 和 C5a 受体 2 在实验性脑膜炎奈瑟菌感染中的不同作用。
Virulence. 2019 Dec;10(1):677-694. doi: 10.1080/21505594.2019.1640035.
10
Anaphylatoxin Receptors C3aR and C5aR1 Are Important Factors That Influence the Impact of Ethanol on the Adipose Secretome.过敏毒素受体 C3aR 和 C5aR1 是影响乙醇对脂肪细胞分泌组影响的重要因素。
Front Immunol. 2018 Sep 20;9:2133. doi: 10.3389/fimmu.2018.02133. eCollection 2018.

引用本文的文献

1
Enigmatic Roles of Complement Anaphylatoxin Signaling in Health and Disease.补体过敏毒素信号在健康与疾病中的神秘作用
Immune Netw. 2025 Aug 20;25(4):e32. doi: 10.4110/in.2025.25.e32. eCollection 2025 Aug.
2
Inhibition of Alternative and Terminal Complement Pathway Components Modulate the Immune Response Against Bacteria and Fungi in Whole Blood.替代和终末补体途径成分的抑制调节全血中针对细菌和真菌的免疫反应。
Scand J Immunol. 2025 May;101(5):e70030. doi: 10.1111/sji.70030.
3
Metamizole outperforms meloxicam in sepsis: insights on analgesics, survival and immunomodulation in the peritoneal contamination and infection sepsis model.

本文引用的文献

1
Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock.使用IFNγ/IL10比值对感染性休克患者氢化可的松治疗进行分层
Front Immunol. 2021 Mar 9;12:607217. doi: 10.3389/fimmu.2021.607217. eCollection 2021.
2
Molecular signatures of liver dysfunction are distinct in fungal and bacterial infections in mice.在小鼠的真菌感染和细菌感染中,肝功能障碍的分子特征明显不同。
Theranostics. 2018 Jun 13;8(14):3766-3780. doi: 10.7150/thno.24333. eCollection 2018.
3
Remembering Pathogen Dose: Long-Term Adaptation in Innate Immunity.
在脓毒症中,安乃近的表现优于美洛昔康:对腹膜污染和感染性脓毒症模型中镇痛药、生存率及免疫调节的见解
Front Immunol. 2024 Aug 30;15:1432307. doi: 10.3389/fimmu.2024.1432307. eCollection 2024.
4
Identification of a genetic region linked to tolerance to MRSA infection using Collaborative Cross mice.利用合作性杂交小鼠鉴定与耐甲氧西林金黄色葡萄球菌感染相关的遗传区域。
PLoS Genet. 2024 Aug 23;20(8):e1011378. doi: 10.1371/journal.pgen.1011378. eCollection 2024 Aug.
5
Enhancing acute inflammatory and sepsis treatment: superiority of membrane receptor blockade.增强急性炎症和脓毒症治疗:膜受体阻断的优越性。
Front Immunol. 2024 Jul 16;15:1424768. doi: 10.3389/fimmu.2024.1424768. eCollection 2024.
6
Dysregulation of Host-Pathogen Interactions in Sepsis: Host-Related Factors.脓毒症中宿主-病原体相互作用的失调:宿主相关因素。
Semin Respir Crit Care Med. 2024 Aug;45(4):469-478. doi: 10.1055/s-0044-1787554. Epub 2024 Jul 1.
7
Immunotherapy in the context of sepsis-induced immunological dysregulation.脓毒症诱导免疫失调的免疫治疗。
Front Immunol. 2024 May 21;15:1391395. doi: 10.3389/fimmu.2024.1391395. eCollection 2024.
8
Active immunotherapy for C5a-mediated inflammation using adjuvant-free self-assembled peptide nanofibers.使用无佐剂自组装肽纳米纤维进行 C5a 介导炎症的主动免疫治疗。
Acta Biomater. 2024 Apr 15;179:83-94. doi: 10.1016/j.actbio.2024.02.042. Epub 2024 Mar 5.
9
Raman Spectroscopy Profiling of Splenic T-Cells in Sepsis and Endotoxemia in Mice.拉曼光谱分析脓毒症和内毒素血症小鼠脾 T 细胞特征。
Int J Mol Sci. 2023 Jul 27;24(15):12027. doi: 10.3390/ijms241512027.
10
RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis.肝细胞中 RIPK3 启动子的高甲基化可防止胆汁酸诱导的炎症和坏死性凋亡。
Cell Death Dis. 2023 Apr 18;14(4):275. doi: 10.1038/s41419-023-05794-0.
铭记病原体剂量:固有免疫的长期适应。
Trends Immunol. 2018 Jun;39(6):438-445. doi: 10.1016/j.it.2018.04.001. Epub 2018 Apr 30.
4
Complement C5a Receptor 1 Exacerbates the Pathophysiology of Sepsis and Is a Potential Target for Disease Treatment.补体 C5a 受体 1 加重脓毒症的病理生理学改变,是疾病治疗的潜在靶点。
mBio. 2018 Jan 23;9(1):e01755-17. doi: 10.1128/mBio.01755-17.
5
Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas.大量副神经节瘤中生长抑素、CXCR4趋化因子和内皮素A受体表达的评估
Oncotarget. 2017 Sep 23;8(52):89958-89969. doi: 10.18632/oncotarget.21194. eCollection 2017 Oct 27.
6
Fast simultaneous assessment of renal and liver function using polymethine dyes in animal models of chronic and acute organ injury.利用多甲川染料在慢性和急性器官损伤动物模型中快速同时评估肾功能和肝功能。
Sci Rep. 2017 Nov 13;7(1):15397. doi: 10.1038/s41598-017-14987-5.
7
Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways.补体 C5a 通过 Erk1/2 和 JNK 信号通路诱导 PD-L1 表达,并与 LPS 协同作用。
Sci Rep. 2016 Sep 14;6:33346. doi: 10.1038/srep33346.
8
C5L2, the Second C5a Anaphylatoxin Receptor, Suppresses LPS-Induced Acute Lung Injury.C5L2,即第二种C5a过敏毒素受体,可抑制脂多糖诱导的急性肺损伤。
Am J Respir Cell Mol Biol. 2016 Nov;55(5):657-666. doi: 10.1165/rcmb.2016-0067OC.
9
Complement activation in the context of stem cells and tissue repair.干细胞与组织修复背景下的补体激活
World J Stem Cells. 2015 Sep 26;7(8):1090-108. doi: 10.4252/wjsc.v7.i8.1090.
10
A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.一种用抗C5aR1抗体与C5小干扰RNA的新型偶联物治疗小鼠关节炎的新方法。
J Immunol. 2015 Jun 1;194(11):5446-54. doi: 10.4049/jimmunol.1403012. Epub 2015 Apr 27.